Foxf1 gene increases the risk of osteoporosis in rats by inhibiting osteoblast formation and promoting osteoclast differentiation through the upregulation of NF-κB pathway
- PMID: 35642703
- PMCID: PMC9186464
Foxf1 gene increases the risk of osteoporosis in rats by inhibiting osteoblast formation and promoting osteoclast differentiation through the upregulation of NF-κB pathway
Abstract
Objectives: a) To explore the expression of Foxf1 and NF-κB in bone tissue of ovariectomized rats with osteoporosis and b) to investigate the role and mechanism of NF-κB pathway regulated by Foxf1 gene in the differentiation and formation of rat osteoclasts and osteoblasts with cell experiments.
Methods: Ovariectomized rat model of osteoporosis was established with 3-month-old female SD rats. The rats were divided into sham group (n=10) and osteoporosis group (n=10). Real time fluorescent quantitative PCR and Western blot were used to detect the expression levels of Foxf1 and NF-κB genes and proteins in the femur tissues of rats and analyze their correlation.
Results: Both Foxf1 and NF- κB were highly expressed in the femur tissues. Upon the overexpression of Foxf1 gene in osteoblasts and osteoclasts in vitro, the gene and protein expression of NF-κB were also upregulated, significantly reducing the gene and protein expression levels of osteogenic factors, including ATF4, OCN, ALP and Runx2.
Conclusions: Foxf1 gene could inhibit osteoblast formation and promote osteoclast differentiation by NF-κB pathway, which may increase the risk of osteoporosis in rats.
Keywords: Foxf1 Gene; NF-κB Pathway; Osteoblasts; Osteoclasts; Osteoporosis.
Conflict of interest statement
The authors have no conflict of interest.
Figures




Similar articles
-
MicroRNA-539 promotes osteoblast proliferation and differentiation and osteoclast apoptosis through the AXNA-dependent Wnt signaling pathway in osteoporotic rats.J Cell Biochem. 2018 Nov;119(10):8346-8358. doi: 10.1002/jcb.26910. Epub 2018 Jun 12. J Cell Biochem. 2018. Retraction in: J Cell Biochem. 2021 Nov;122 Suppl 1:S96. doi: 10.1002/jcb.30064. PMID: 29893431 Retracted.
-
Apolipoprotein E plays crucial roles in maintaining bone mass by promoting osteoblast differentiation via ERK1/2 pathway and by suppressing osteoclast differentiation via c-Fos, NFATc1, and NF-κB pathway.Biochem Biophys Res Commun. 2018 Sep 5;503(2):644-650. doi: 10.1016/j.bbrc.2018.06.055. Epub 2018 Jun 15. Biochem Biophys Res Commun. 2018. PMID: 29906458
-
Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.EBioMedicine. 2020 Feb;52:102626. doi: 10.1016/j.ebiom.2020.102626. Epub 2020 Jan 22. EBioMedicine. 2020. PMID: 31981979 Free PMC article.
-
Advances in the roles of ATF4 in osteoporosis.Biomed Pharmacother. 2023 Dec 31;169:115864. doi: 10.1016/j.biopha.2023.115864. Epub 2023 Nov 9. Biomed Pharmacother. 2023. PMID: 37948991 Review.
-
[NF-κB signaling pathways and the future perspectives of bone disease therapy using selective inhibitors of NF-κB].Clin Calcium. 2016 Feb;26(2):298-304. Clin Calcium. 2016. PMID: 26813510 Review. Japanese.
Cited by
-
Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway.Aging (Albany NY). 2024 Aug 27;16(17):12263-12276. doi: 10.18632/aging.206084. Epub 2024 Aug 27. Aging (Albany NY). 2024. PMID: 39197167 Free PMC article.
-
LINC01133 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by upregulating CTNNB1 by acting as a sponge for miR-214-3p.J Orthop Surg Res. 2024 Sep 16;19(1):572. doi: 10.1186/s13018-024-05053-8. J Orthop Surg Res. 2024. PMID: 39285416 Free PMC article.
-
Genomic structural variations link multiple genes to bone mineral density in a multi-ethnic cohort study: Louisiana osteoporosis study.J Bone Miner Res. 2024 Sep 26;39(10):1474-1485. doi: 10.1093/jbmr/zjae133. J Bone Miner Res. 2024. PMID: 39167757 Free PMC article.
-
Association of sdLDL-C/LDL-C ratio with atherosclerotic cardiovascular disease: a case-control study.BMC Cardiovasc Disord. 2025 Jun 3;25(1):430. doi: 10.1186/s12872-025-04871-w. BMC Cardiovasc Disord. 2025. PMID: 40457209 Free PMC article.
References
-
- Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393:364–376. - PubMed
-
- Porter JL, Varacallo M. Osteoporosis. StatPearls. Treasure Island (FL):StatPearls Publishing Copyright ©2020, StatPearls Publishing LLC, 2020
-
- van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone. 2001;29:517–522. - PubMed
-
- Eastell R, O'Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069. - PubMed